about
Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas.Clinical complementarities between proton and carbon therapies.A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.[Is proton beam therapy the future of radiotherapy? Part I: clinical aspects].Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.Investigation of ectopic recurrent skull base and cervical chordomas: The Institut Curie's proton therapy center experience.Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors.Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
P50
Q33272239-C380D3E0-D810-4D37-8D9E-C31AC5F0147EQ33272353-71A255AE-D0A7-4848-8F47-DFCE06944A32Q33272943-31181FC9-E417-42F8-AFF3-C9C0AA329EA8Q33273784-EAB9BF56-AE1F-482D-889B-13AB91513010Q33274404-5C05DC7E-BCA9-4198-894F-A2D6C8C2B5ABQ33275739-9902BFAE-52B8-4FD6-A02F-F3DC096AC24BQ33275854-2E2998C0-9F03-49D8-AEB1-94E955E4BB58Q33276494-DBB17575-2536-4920-B4A2-9D1AD5A9C062
P50
description
onderzoeker
@nl
name
Loïc Feuvret
@ast
Loïc Feuvret
@en
Loïc Feuvret
@nl
Loïc Feuvret
@sl
type
label
Loïc Feuvret
@ast
Loïc Feuvret
@en
Loïc Feuvret
@nl
Loïc Feuvret
@sl
prefLabel
Loïc Feuvret
@ast
Loïc Feuvret
@en
Loïc Feuvret
@nl
Loïc Feuvret
@sl